DHT.health

At DHT.health, we exist to make a difference in rare and underserved diseases by creating meaningful change through research. We generate hard-to-access data, deliver robust analysis, and turn evidence into action. Our work helps patients gain faster access to treatments and supports biopharma, medtech, and healthcare stakeholders with the insights they need to make informed decisions. Our core services include: • 𝗘𝘃𝗶𝗱𝗲𝗻𝗰𝗲 & 𝗜𝗻𝘀𝗶𝗴𝗵𝘁𝘀 𝗚𝗲𝗻𝗲𝗿𝗮𝘁𝗶𝗼𝗻 – from qualitative research to real-world data collection • 𝗘𝘃𝗶𝗱𝗲𝗻𝗰𝗲 & 𝗜𝗻𝘀𝗶𝗴𝗵𝘁𝘀 𝗖𝗼𝗺𝗺𝘂𝗻𝗶𝗰𝗮𝘁𝗶𝗼𝗻 – making data understandable, impactful, and accessible • 𝗛𝗲𝗮𝗹𝘁𝗵 𝗘𝗰𝗼𝗻𝗼𝗺𝗶𝗰𝘀 & 𝗗𝗮𝘁𝗮 𝗦𝗰𝗶𝗲𝗻𝗰𝗲 – translating complexity into clarity • 𝗘𝗱𝘂𝗰𝗮𝘁𝗶𝗼𝗻 & 𝗘𝗻𝗴𝗮𝗴𝗲𝗺𝗲𝗻𝘁 – supporting collaboration between industry, patients, and advocacy groups DHT was founded by Sam Bristow and George Morgan to bridge the gap between pharmaceutical innovation and the lived experience of patients and families. From the beginning, we have worked alongside patient communities to shape research that reflects their reality, starting with the creation of the 𝗣𝗜𝗩𝗢𝗧 methodology. Today, we continue to combine rigorous research, patient-centred thinking, and health economics to drive meaningful change. Our vision is a world where no community is left behind, and everyone impacted by a health condition benefits from the research, evidence, and healthcare they deserve.